Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
102 studies found for:    Open Studies | "Exanthema"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Exanthema"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Regulatory T Cells (Tregs) in Polymorphic Light Eruption
Conditions: Polymorphic Light Eruption;   Psoriasis;   Atopic Eczema
Intervention:
2 Recruiting Vitamin D Supplementation in Polymorphic Light Eruption
Condition: Polymorphic Light Eruption
Interventions: Drug: Oral Vitamin D 3;   Drug: Miglyol 812 N
3 Not yet recruiting Determination of Safety and Consumers' Satisfaction of Moussik Versus Desitin Creamy Ointment in Diaper Rash Prophylaxis
Condition: Diaper Rash
Interventions: Other: Moussik Diaper Rash Mousse;   Other: Desitin Creamy Ointment
4 Recruiting 1% Topical Pimecrolimus Cream for the Treatment of the Rash Associated With ERBITUX
Condition: Rash
Intervention: Drug: Pimecrolimus
5 Recruiting Evaluating Preventive Therapy With Oint Threolone, Synthomycine or Aqua Cream Lotion, for EGFR'I Induced Acneiform Rash
Condition: Acneiform Rash
Interventions: Drug: Threolone ointment;   Drug: ointment Synthomycine;   Drug: Aqua cream lotion
6 Recruiting Tetracycline as a Prophylaxis for Rash in Patients With NSCLC Receiving Treatment With BIBW 2992
Conditions: Skin Rash;   Lung Cancer
Intervention: Drug: Tetracycline
7 Recruiting Study of Prophylactic Topical Dapsone 5% Gel Versus Moisturizer for Cetuximab-induced Papulopustular (Acneiform) Rash in Patients With mCRC or HNSCC Without Previous or Concurrent RT
Conditions: Cetuximab-induced Papulopustular (Acneiform) Rash Who Have;   Metastatic Colorectal Cancer or Head and Neck Squamous Cell Carcinoma
Interventions: Drug: Topical Dapsone 5% Gel;   Other: Moisturizer;   Drug: oral antibiotics
8 Recruiting Bepanthen Versus Cetomacrogol in Epidermal Growth Factor Receptor Inhibitors (EGFRI)
Conditions: Cancer;   Skin Rash
Intervention: Other: cream
9 Not yet recruiting Evaluation of the Quality of Self-collected Blood Spot Specimens for Laboratory HIV Testing - An InvolveMENt Sub Study
Conditions: HIV;   Dried Blood Spot Method
Intervention: Other: Number of DBS Spots
10 Not yet recruiting A Study to Examine the Effect of Reconval K1 Cream to Prevent Skin Toxicity From EGFRI
Condition: Rash Due to Epidermal Growth Factor Receptor Inhibitors
Interventions: Drug: RECONVAL CREAM;   Drug: PLACEBO
11 Recruiting Comparison Between Corticosteroid and Topical Steroids in the DRESS
Condition: Drug Rash With Eosinophilia and Systemic Symptoms
Interventions: Drug: Prednisone;   Drug: Clobetasol
12 Recruiting Clinical Effectiveness of Various Professionally Applied Fluoride Prophylaxes in Groups at High Risk
Conditions: White Spot Lesion;   Caries
Intervention: Other: Fluor Protector S
13 Unknown  Does Acne Rash During Adolescence Predict Skin Reaction to Cetuximab
Condition: Colorectal Cancer Metastatic
Intervention: Drug: Cetuximab
14 Recruiting Pre-Exposure Prophylaxis (PrEP) Adherence Monitoring Using Dried Blood Spots
Condition: PrEP Adherence Monitoring
Intervention: Drug: Truvada
15 Unknown  Elmex Gel Efficacy in Preventing White Spot Lesions
Condition: Dental Caries
Intervention: Drug: elmex gel
16 Unknown  Retinal Laser by Multi-spot Photocoagulator and Driving Eligibility
Condition: Proliferative Diabetic Retinopathy
Intervention: Procedure: Pan retinal Photocoagulation
17 Not yet recruiting Safety, Tolerability and Efficacy Study of Doxycycline Foam for the Prevention of EGFRI Skin Toxicity in Cancer Patients
Condition: Rash Due to Epidermal Growth Factor Receptor Inhibitors
Intervention: Drug: FDX104 (4% Doxycycline)
18 Recruiting Multi-Compression Spot Mammography
Condition: Breast Diseases
Intervention:
19 Not yet recruiting Laser Spot Treatment of Perioral Rhytids
Condition: Facial Aging
Intervention: Device: Laser Treatment
20 Recruiting The Spot Sign for Predicting and Treating ICH Growth Study
Condition: Intracerebral Hemorrhage
Interventions: Drug: recombinant activated factor VII;   Drug: placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years